4 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Pharmacokinetics and Safety of MDR-001 in Mild and Moderate Hepatic ImpairmentDigestive System Diseases, Hemic and Lymphatic Diseases, Hepatic Insufficiency, Neoplasms by Histologic Type, follicular lymphoma, immune system disorder, immunoproliferative disorder, liver disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasmNot yet recruitingPhase 12026-04-24NCT07550634
Drug-Drug Interaction Study of MDR-001 With Rifampin and Itraconazole in Healthy Adult ParticipantsHealthy Volunteers (HV)Not yet recruitingPhase 12026-04-24NCT07550621
A Phase III Study to Evaluate the Efficacy and Safety of MDR-001 in Adult Participants With Overweight or Obesity (MOBILE)Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutritionNot yet recruitingPhase 32025-12-22NCT07274137
Phase Ib Clinical Study on the Efficacy and Safety of MDR-001 in Patients Who Are Obesity or OverweightBody Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutritionNot yet recruitingPhase 12025-08-08NCT07110766